RESUMEN
BACKGROUND: Approximately 10% of people with cystic fibrosis (CF) have mutations that result in little to no CFTR production and thus cannot benefit from CFTR modulators. We previously found that Amphotericin B (AmB), a small molecule that forms anion channels, restored HCO3- secretion and increased host defenses in primary cultures of CF airway epithelia. Further, AmB increased ASL pH in CFTR-null pigs, suggesting an alternative CFTR-independent approach to achieve gain-of-function. However, it remains unclear whether this approach can be effective in people. METHODS: To determine whether AmB can impact physiology in people with CF, we first tested whether Fungizone, a clinically approved AmB formulation, could cause electrophysiological effects consistent with anion secretion in primary cultures of CF airway epithelia. We then evaluated the capacity of AmB to change nasal potential difference (NPD), a key clinical biomarker, in people with CF not on CFTR modulators. RESULTS: AmB increased transepithelial Cl- current and hyperpolarized calculated transepithelial voltage in primary cultures of CF airway epithelia from people with two nonsense mutations. In eight people with CF not on CFTR modulators, intranasal Fungizone treatment caused a statistically significant change in NPD. This change was similar in direction and magnitude to the effect of ivacaftor in people with a G551D mutation. CONCLUSIONS: Our results provide the first evidence that AmB can impact a clinical biomarker in people with CF. These results encourage additional clinical studies in people with CF to determine whether small molecule anion channels can provide benefit.
Asunto(s)
Anfotericina B/farmacología , Antifúngicos/farmacología , Regulador de Conductancia de Transmembrana de Fibrosis Quística/efectos de los fármacos , Fibrosis Quística/tratamiento farmacológico , Canales Aniónicos Dependientes del Voltaje/efectos de los fármacos , Administración Intranasal , Anfotericina B/administración & dosificación , Antifúngicos/administración & dosificación , Células Cultivadas , Codón sin Sentido , Fibrosis Quística/genética , Humanos , Mucosa Respiratoria/citologíaRESUMEN
Iloperidone, a second-generation atypical antipsychotic drug, is widely used in the treatment of schizophrenia. However, the side-effects of iloperidone on vascular K+ channels remain to be determined. Therefore, we explored the effect of iloperidone on voltage-dependent K+ (Kv) channels in rabbit coronary arterial smooth muscle cells using the whole-cell patch-clamp technique. Iloperidone inhibited vascular Kv channels in a concentration-dependent manner with a half-maximal inhibitory concentration (IC50 ) of 2.11 ± 0.5 µM and a Hill coefficient of 0.68 ± 0.03. Iloperidone had no effect on the steady-state inactivation kinetics. However, it shifted the steady-state activation curve to the right, indicating that iloperidone inhibited Kv channels by influencing the voltage sensors. Application of 20 repetitive depolarizing pulses (1 and 2 Hz) progressively increased the inhibition of the Kv current in the presence of iloperidone. Furthermore, iloperidone increased the recovery time constant from Kv channel inactivation, suggesting that iloperidone-induced inhibition of Kv channels is use (state)-dependent. Pretreatment with a Kv1.5 inhibitor (diphenyl phosphine oxide 1 [DPO-1]) inhibited the Kv current to a level similar to that with iloperidone alone. However, pretreatment with a Kv2.1 or Kv7.X inhibitor (guangxitoxin or linopirdine) did not affect the inhibitory effect of iloperidone on Kv channels. Therefore, iloperidone directly inhibits Kv channels in a concentration- and use (state)-dependent manner independently of its antagonism of serotonin and dopamine receptors. Furthermore, the primary target of iloperidone is the Kv1.5 subtype.
Asunto(s)
Antipsicóticos/toxicidad , Vasos Coronarios/efectos de los fármacos , Isoxazoles/toxicidad , Potenciales de la Membrana/efectos de los fármacos , Miocitos del Músculo Liso/efectos de los fármacos , Piperidinas/toxicidad , Canales Aniónicos Dependientes del Voltaje/efectos de los fármacos , Antipsicóticos/uso terapéutico , Bloqueadores de los Canales de Potasio , Esquizofrenia/tratamiento farmacológicoRESUMEN
The yolk sac is the first site of blood-cell production during embryonic development in both murine and human. Heat shock proteins (HSPs), including HSP70 and HSP27, have been shown to play regulatory roles during erythropoiesis. However, it remains unknown whether HSP60, a molecular chaperone that resides mainly in mitochondria, could also regulate early erythropoiesis. In this study, we used Tie2-Cre to deactivate the Hspd1 gene in both hematopoietic and vascular endothelial cells, and found that Tie2-Cre+Hspd1f/f (HSP60CKO) mice were embryonic lethal between the embryonic day 10.5 (E10.5) and E11.5, exhibiting growth retardation, anemia, and vascular defects. Of these, anemia was observed first, independently of vascular and growth phenotypes. Reduced numbers of erythrocytes, as well as an increase in cell apoptosis, were found in the HSP60CKO yolk sac as early as E9.0, indicating that deletion of HSP60 led to abnormality in yolk sac erythropoiesis. Deletion of HSP60 was also able to reduce mitochondrial membrane potential and the expression of the voltage-dependent anion channel (VDAC) in yolk sac erythrocytes. Furthermore, cyclosporine A (CsA), which is a well-recognized modulator in regulating the opening of the mitochondrial permeability transition pore (mPTP) by interacting with Cyclophilin D (CypD), could significantly decrease cell apoptosis and partially restore VDAC expression in mutant yolk sac erythrocytes. Taken together, we demonstrated an essential role of HSP60 in regulating yolk sac cell survival partially via a mPTP-dependent mechanism.
Asunto(s)
Chaperonina 60/metabolismo , Desarrollo Embrionario/genética , Eritropoyesis/genética , Proteínas Mitocondriales/metabolismo , Saco Vitelino/citología , Anemia/genética , Animales , Apoptosis/efectos de los fármacos , Apoptosis/genética , Chaperonina 60/genética , Ciclosporina/farmacología , Embrión de Mamíferos/metabolismo , Embrión de Mamíferos/fisiopatología , Células Endoteliales/metabolismo , Eritrocitos/metabolismo , Eritropoyesis/fisiología , Femenino , Regulación del Desarrollo de la Expresión Génica/genética , Células Madre Hematopoyéticas/metabolismo , Potencial de la Membrana Mitocondrial/efectos de los fármacos , Potencial de la Membrana Mitocondrial/genética , Ratones , Proteínas Mitocondriales/genética , Embarazo , Canales Aniónicos Dependientes del Voltaje/efectos de los fármacos , Canales Aniónicos Dependientes del Voltaje/metabolismo , Saco Vitelino/crecimiento & desarrollo , Saco Vitelino/metabolismo , Saco Vitelino/patologíaRESUMEN
Dietary trans fatty acids (TFAs) are known to increase the risk of cardiovascular diseases by altering plasma lipid profile and activating various inflammatory signaling pathways. Here we show that elaidic acid (EA), the most abundant TFA in diet, alters the electrophysiological properties of voltage-dependent anion channel (VDAC) of mitochondria. Purified bovine brain VDAC, when incorporated in the planar lipid bilayer (PLB) composed of 1,2-diphytanoyl-sn-glycero-3 phosphatidyl choline (DPhPC) and EA in a 9 to 1 ratio (wt/wt), exhibited complete closing events at different voltages. The closing events were observed at even -10 mV, a voltage at which VDAC usually remains fully open all the time. Additionally, the voltage sensitivity of VDAC was lost in presence of EA; the channel conductance did not decrease with increasing voltages. In identical experimental conditions, membrane containing oleic acid (OA), the cis isomer of EA did not produce any such effect. We propose that EA possibly exerts its adverse effect by modulating VDAC.
Asunto(s)
Mitocondrias/fisiología , Ácido Oléico/farmacología , Canales Aniónicos Dependientes del Voltaje/efectos de los fármacos , Animales , Mitocondrias/efectos de los fármacos , Ácidos Oléicos , Canales Aniónicos Dependientes del Voltaje/fisiologíaRESUMEN
Glucokinase plays a key role in the metabolism of glucose by pancreatic ß-cells. In this study the effects of the glucokinase activator GKA50 on cell volume and electrical activity in rat ß-cells were examined. One micro molar GKA50 caused an increase in ß-cell volume in the presence of 4mM glucose. GKA50 also caused a depolarisation of ß-cell membrane potential and increased electrical activity. These changes were associated with the activation of inward whole-cell currents, and were attenuated by the anion channel inhibitor 5-nitro-2-(3-phenylpropylamino) benzoic acid. In single channel experiments, the open probability of volume-regulated anion channels (VRAC) was increased from 0.03±0.01 to 0.19±0.04 (n=3) by the GKA50. The data suggest that a GKA50-evoked increase in glucose metabolism causes an increase in ß-cell volume. This in turn activates VRAC leading to a depolarisation of the cell membrane potential.
Asunto(s)
Tamaño de la Célula/efectos de los fármacos , Células Secretoras de Insulina/efectos de los fármacos , Células Secretoras de Insulina/metabolismo , Piridinas/farmacología , Canales Aniónicos Dependientes del Voltaje/efectos de los fármacos , Animales , Transporte Biológico , Células Cultivadas , Glucoquinasa/metabolismo , Glucosa/metabolismo , Células Secretoras de Insulina/citología , Potenciales de la Membrana/efectos de los fármacos , Potenciales de la Membrana/fisiología , Nitrobenzoatos/farmacología , Técnicas de Placa-Clamp , Ratas , Ratas Sprague-DawleyRESUMEN
Nitric oxide (NO·) effects on the cardiac mitochondrial voltage-dependent anion channel (VDAC) are unknown. The effects of exogenous NO· on VDAC purified from rat hearts were investigated in this study. When incorporated into lipid bilayers, VDAC was inhibited directly by an NO· donor, PAPA NONOate, in a concentration-dependent biphasic manner. This was prevented by an NO· scavenger, 2-phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide. The effect paralleled that of NO() in delaying the opening of the mitochondrial permeability transition (PT) pore. These biphasic effects on the cardiac VDAC and the mitochondrial PT pore reveal a tandem impact of NO() on the two mitochondrial entities.
Asunto(s)
Óxido Nítrico/farmacología , Canales Aniónicos Dependientes del Voltaje/efectos de los fármacos , Animales , Relación Dosis-Respuesta a Droga , Técnicas Electrofisiológicas Cardíacas , Corazón/fisiología , Proteínas de Transporte de Membrana Mitocondrial/efectos de los fármacos , Poro de Transición de la Permeabilidad Mitocondrial , Miocardio/química , Miocardio/metabolismo , RatasRESUMEN
BACKGROUND AND AIM: Chinese traditional medical science is generally used as a therapeutic method against functional dyspepsia (FD) in China. Although great effort is made to understand the pharmaceutical mechanisms of Chinese traditional medicine, such as typical traditional Chinese medicine, Wei Kangning, there are still many mysteries to be uncovered. METHODS: The model of FD was established by stimulating rats via tail damping and the rats were treated with traditional Chinese medicine, Wei Kangning. The proteins of the rat gastrointestinal tissues were extracted and run by 2-DE, then the differential proteins were identified using matrix-assisted laser desorption ionisation time-of-flight mass spectrometry and validated with Western blotting or fluorescent quantitation polymerase chain reaction. RESULTS: A total of 228 unique proteins in FD model rats were detected with significant changes in their expression levels corresponding with traditional Chinese medicine, Wei Kangning, administration. Twenty-eight of these proteins were identified, which are involved in many biological functions, such as organism antioxidant enzymes, energy metabolism, glutathione S-transferase, pi2, superoxide dismutase 2 and alpha-enolase and so on. CONCLUSIONS: These proteomic results presented therefore provide additional support to the hypothesis that glutathione S-transferase, pi2, superoxide dismutase 2, α-enolase and voltage-dependent anion channel are the targets of FD treated with traditional Chinese medicine, Wei Kangning.
Asunto(s)
Medicamentos Herbarios Chinos/farmacología , Dispepsia/tratamiento farmacológico , Intestinos/efectos de los fármacos , Proteómica , Estómago/efectos de los fármacos , Estrés Psicológico/complicaciones , Animales , Western Blotting , Modelos Animales de Enfermedad , Dispepsia/etiología , Dispepsia/metabolismo , Dispepsia/fisiopatología , Electroforesis en Gel Bidimensional , Mucosa Gástrica/metabolismo , Motilidad Gastrointestinal/efectos de los fármacos , Gutatión-S-Transferasa pi/metabolismo , Mucosa Intestinal/metabolismo , Intestinos/fisiopatología , Fosfopiruvato Hidratasa/metabolismo , Proteómica/métodos , Ratas , Ratas Wistar , Reacción en Cadena en Tiempo Real de la Polimerasa , Reproducibilidad de los Resultados , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Espectrometría de Masa por Láser de Matriz Asistida de Ionización Desorción , Estómago/fisiopatología , Superóxido Dismutasa/metabolismo , Canales Aniónicos Dependientes del Voltaje/efectos de los fármacos , Canales Aniónicos Dependientes del Voltaje/metabolismoRESUMEN
OBJECTIVE: To investigate the effect of morphine preconditioning on mitochondrial permeability transition pore (MPTP) and its protective mechanism after myocardial ischemia-reperfusion injury. METHODS: A rat model of ischemia-reperfusion injury was established. Forty rats were injected with 2-(3)[H] DOG and then divided into 4 groups randomly: a sham operation (S) group, an ischemia-reperfusion injury (IR) group, a morphine preconditioning (Mp+IR) group, and a cyclosporine A preconditioning (CsA+IR) group. We monitored the concentrations of serum creatine kinase-Mb (CK-Mb) and cardiac troponin I (cTnI), and measured myocardial mitochondrial 2-(3)[H] DOG, cytochrome c content, Ca(2+) concentration ([Ca(2+)]m), the velocity of Ca(2+) intake and reaction half time of mitochondrial permeability transition pore (MPTP t(1/2)) in the 4 groups. RESULTS: The concentrations of serum CK-Mb and cTnI decreased more in the Mp+IR group and the CsA+IR group than those of the IR group. The concentrations of 2-(3)[H]DOG and [Ca(2+)]m in the IR group were evidently higher but the level of cytochrome c was lower than those of the sham operation group. The concentrations of 2-(3)[H] DOG and [Ca(2+)]m in the Mp+IR group decreased whereas the concentration of cytochrome c increased compared with those in the IR group. Mitochondrial 2-(3)[H]DOG content was positively correlated with the concentration of calcium (r=0.797, P<0.01). The 2-(3)[H]DOG and [Ca(2+)]m content were negatively correlated with cytochrome c in the IR group (r=-0.805 and r=-0.648, respectively, P<0.01). MPTP t(1/2) in the IR group was shortened evidently, and that in the Mp+IR and CsA+IR group was significantly lengthened. CONCLUSION: Morphine preconditioning may have myocardial protective effect through unburdening the calcium overload and lengthening the MPTP t(1/2).
Asunto(s)
Permeabilidad de la Membrana Celular/efectos de los fármacos , Precondicionamiento Isquémico Miocárdico/métodos , Morfina/farmacología , Daño por Reperfusión Miocárdica/metabolismo , Canales Aniónicos Dependientes del Voltaje/efectos de los fármacos , Animales , Calcio/metabolismo , Masculino , Mitocondrias/metabolismo , Morfina/uso terapéutico , Daño por Reperfusión Miocárdica/tratamiento farmacológico , Distribución Aleatoria , Ratas , Ratas Sprague-DawleyAsunto(s)
Secretasas de la Proteína Precursora del Amiloide/metabolismo , Precursor de Proteína beta-Amiloide/fisiología , Apoptosis/fisiología , Ácido Aspártico Endopeptidasas/metabolismo , Canales Aniónicos Dependientes del Voltaje/efectos de los fármacos , Precursor de Proteína beta-Amiloide/metabolismo , Animales , Humanos , RatonesAsunto(s)
Hidróxido de Aluminio/efectos adversos , Enfermedad de Alzheimer/fisiopatología , Esclerosis Amiotrófica Lateral/fisiopatología , Canales Aniónicos Dependientes del Voltaje/efectos de los fármacos , Animales , Anticuerpos/farmacología , Apoptosis/efectos de los fármacos , Gadolinio/farmacología , Humanos , Ratones , Neuronas Motoras/efectos de los fármacos , Canales Aniónicos Dependientes del Voltaje/inmunologíaAsunto(s)
Toxinas Marinas/toxicidad , Neuronas/efectos de los fármacos , Compuestos de Espiro/toxicidad , Canales Aniónicos Dependientes del Voltaje/efectos de los fármacos , Animales , Apoptosis/efectos de los fármacos , Tamaño de la Célula/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Células Cultivadas , Humanos , Péptidos y Proteínas de Señalización Intracelular , Ratones , Ratones Noqueados , Proteínas de Neoplasias/metabolismo , Neuronas/metabolismo , Neuronas/patología , Unión Proteica , Receptores de Superficie Celular/metabolismo , Canales Aniónicos Dependientes del Voltaje/metabolismoRESUMEN
Lead (Pb) has been shown to disrupt cellular energy metabolism, which may underlie the learning deficits and cognitive dysfunctions associated with environmental Pb exposure. The voltage-dependent anion channel (VDAC) plays a central role in regulating energy metabolism in neurons by maintaining cellular ATP levels and regulating calcium buffering, and studies have shown that VDAC expression is associated with learning in mice. In this study, we examined the effect of 5 and 10microM Pb on VDAC expression in vitro in order to determine whether Pb alters VDAC expression levels in neuronal cell lines. PC-12 and SH-SY5Y cells were used since they differentiate to resemble primary neuronal cells. VDAC expression levels were significantly decreased 48 h after exposure to Pb in both cell lines. In contrast, exposure to 24 h of hypoxia failed to produce a decrease in VDAC, suggesting that decreased VDAC expression is not a general cellular stress response but is a result of Pb exposure. This decreased VDAC expression was also correlated with a corresponding decrease in cellular ATP levels. Real-time reverse transcription-polymerase chain reaction demonstrated a significant decrease in messenger RNA levels for the VDAC1 isoform, indicating that Pb reduces transcription of VDAC1. These results demonstrate that exposure to 5 and 10microM Pb reduces VDAC transcription and expression and is associated with reduced cellular ATP levels.
Asunto(s)
Diferenciación Celular , Neuronas/efectos de los fármacos , Compuestos Organometálicos/toxicidad , Canales Aniónicos Dependientes del Voltaje/efectos de los fármacos , Adenosina Trifosfato/metabolismo , Animales , Western Blotting , Hipoxia de la Célula , Línea Celular Tumoral , Relación Dosis-Respuesta a Droga , Regulación hacia Abajo , Humanos , Neuronas/metabolismo , Neuronas/patología , ARN Mensajero/metabolismo , Ratas , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Factores de Tiempo , Transcripción Genética/efectos de los fármacos , Canal Aniónico 1 Dependiente del Voltaje/efectos de los fármacos , Canal Aniónico 1 Dependiente del Voltaje/metabolismo , Canales Aniónicos Dependientes del Voltaje/genética , Canales Aniónicos Dependientes del Voltaje/metabolismoAsunto(s)
Nucleótidos de Adenina/metabolismo , Cardiotónicos/farmacología , Metabolismo Energético/efectos de los fármacos , Inhibidores Enzimáticos/farmacología , Glucógeno Sintasa Quinasa 3/antagonistas & inhibidores , Mitocondrias Cardíacas/efectos de los fármacos , Daño por Reperfusión Miocárdica/prevención & control , Canales Aniónicos Dependientes del Voltaje/efectos de los fármacos , Animales , Glucógeno Sintasa Quinasa 3/metabolismo , Glucógeno Sintasa Quinasa 3 beta , Humanos , Cinética , Mitocondrias Cardíacas/enzimología , Translocasas Mitocondriales de ADP y ATP/metabolismo , Proteínas de Transporte de Membrana Mitocondrial/metabolismo , Membranas Mitocondriales/efectos de los fármacos , Membranas Mitocondriales/metabolismo , Poro de Transición de la Permeabilidad Mitocondrial , Contracción Miocárdica/efectos de los fármacos , Daño por Reperfusión Miocárdica/enzimología , Fosforilación , Proteínas Proto-Oncogénicas c-akt/metabolismo , Proteínas Proto-Oncogénicas c-bcl-2/metabolismo , ATPasas de Translocación de Protón/metabolismo , Función Ventricular Izquierda/efectos de los fármacos , Canales Aniónicos Dependientes del Voltaje/metabolismoRESUMEN
Inhibition of glycogen synthase kinase (GSK)-3 reduces ischemia/reperfusion injury by mechanisms that involve the mitochondria. The goal of this study was to explore possible molecular targets and mechanistic basis of this cardioprotective effect. In perfused rat hearts, treatment with GSK inhibitors before ischemia significantly improved recovery of function. To assess the effect of GSK inhibitors on mitochondrial function under ischemic conditions, mitochondria were isolated from rat hearts perfused with GSK inhibitors and were treated with uncoupler or cyanide or were made anoxic. GSK inhibition slowed ATP consumption under these conditions, which could be attributable to inhibition of ATP entry into the mitochondria through the voltage-dependent anion channel (VDAC) and/or adenine nucleotide transporter (ANT) or to inhibition of the F(1)F(0)-ATPase. To determine the site of the inhibitory effect on ATP consumption, we measured the conversion of ADP to AMP by adenylate kinase located in the intermembrane space. This assay requires adenine nucleotide transport across the outer but not the inner mitochondrial membrane, and we found that GSK inhibitors slow AMP production similar to their effect on ATP consumption. This suggests that GSK inhibitors are acting on outer mitochondrial membrane transport. In sonicated mitochondria, GSK inhibition had no effect on ATP consumption or AMP production. In intact mitochondria, cyclosporin A had no effect, indicating that ATP consumption is not caused by opening of the mitochondrial permeability transition pore. Because GSK is a kinase, we assessed whether protein phosphorylation might be involved. Therefore, we performed Western blot and 1D/2D gel phosphorylation site analysis using phos-tag staining to indicate proteins that had decreased phosphorylation in hearts treated with GSK inhibitors. Liquid chromatographic-mass spectrometric analysis revealed 1 of these proteins to be VDAC2. Taken together, we found that GSK-mediated signaling modulates transport through the outer membrane of the mitochondria. Both proteomics and adenine nucleotide transport data suggest that GSK regulates VDAC and that VDAC may be an important regulatory site in ischemia/reperfusion injury.
Asunto(s)
Nucleótidos de Adenina/metabolismo , Cardiotónicos/farmacología , Metabolismo Energético/efectos de los fármacos , Inhibidores Enzimáticos/farmacología , Glucógeno Sintasa Quinasa 3/antagonistas & inhibidores , Mitocondrias Cardíacas/efectos de los fármacos , Membranas Mitocondriales/efectos de los fármacos , Canales Aniónicos Dependientes del Voltaje/efectos de los fármacos , Adenosina Difosfato/metabolismo , Adenosina Monofosfato/metabolismo , Adenosina Trifosfato/metabolismo , Aminofenoles/farmacología , Animales , Glucógeno Sintasa Quinasa 3/metabolismo , Glucógeno Sintasa Quinasa 3 beta , Indoles/farmacología , Cinética , Masculino , Maleimidas/farmacología , Mitocondrias Cardíacas/enzimología , Translocasas Mitocondriales de ADP y ATP/metabolismo , Proteínas de Transporte de Membrana Mitocondrial/metabolismo , Membranas Mitocondriales/metabolismo , Poro de Transición de la Permeabilidad Mitocondrial , Contracción Miocárdica/efectos de los fármacos , Daño por Reperfusión Miocárdica/enzimología , Daño por Reperfusión Miocárdica/prevención & control , Fosforilación , Proteínas Proto-Oncogénicas c-akt/metabolismo , Proteínas Proto-Oncogénicas c-bcl-2/metabolismo , ATPasas de Translocación de Protón/metabolismo , Ratas , Ratas Sprague-Dawley , Función Ventricular Izquierda/efectos de los fármacos , Canal Aniónico 2 Dependiente del Voltaje/efectos de los fármacos , Canal Aniónico 2 Dependiente del Voltaje/metabolismo , Canales Aniónicos Dependientes del Voltaje/metabolismoRESUMEN
Microglia are the resident immune cells of the CNS, which are important for preserving neural tissue functions, but may also contribute to neurodegeneration. Activation of these cells in infection, inflammation, or trauma leads to the release of various toxic molecules, including reactive oxygen species (ROS) and the excitatory amino acid glutamate. In this study, we used an electrophysiologic approach and a D-[(3)H]aspartate (glutamate) release assay to explore the ROS-dependent regulation of glutamate-permeable volume-regulated anion channels (VRACs). Exposure of rat microglia to hypo-osmotic media stimulated Cl(-) currents and D-[(3)H]aspartate release, both of which were inhibited by the selective VRAC blocker, DCPIB. Exogenously applied H(2)O(2) potently increased swelling-activated glutamate release. Stimulation of microglia with zymosan triggered production of endogenous ROS and strongly enhanced glutamate release via VRAC in swollen cells. The effects of zymosan were attenuated by the ROS scavenger, MnTMPyP, and by two inhibitors of NADPH oxidase (NOX), diphenyliodonium and thioridazine. However, zymosan-stimulated glutamate release was insensitive to other NOX blockers, apocynin and HEBSF. This pharmacologic profile pointed to the potential involvement of apocynin-insensitive NOX4. Using RT-PCR we confirmed that NOX4 is expressed in rat microglial cells along with NOX1 and NOX2. To check for potential involvement of phagocytic NOX2, we stimulated this isoform using protein kinase C (PKC) activator, phorbol 12-myristate 13-acetate or inhibited it with the broad spectrum PKC blocker, Gö6983. Both agents potently modulated endogenous ROS production by NOX2 but not VRAC activity. Taken together, these data suggest that the anion channel VRAC may contribute to microglial glutamate release and that its activity is regulated by endogenous ROS originating from NOX4.
Asunto(s)
Aminoácidos Excitadores/metabolismo , Microglía/metabolismo , NADPH Oxidasas/metabolismo , Canales Aniónicos Dependientes del Voltaje/metabolismo , Zimosan/farmacología , Animales , Animales Recién Nacidos , Ácido Aspártico/metabolismo , Células Cultivadas , Encefalitis/metabolismo , Inhibidores Enzimáticos/farmacología , Ácido Glutámico/metabolismo , Isoenzimas/efectos de los fármacos , Isoenzimas/metabolismo , Microglía/efectos de los fármacos , NADPH Oxidasa 4 , NADPH Oxidasas/efectos de los fármacos , Oxidantes/farmacología , Estrés Oxidativo/efectos de los fármacos , Estrés Oxidativo/fisiología , Proteína Quinasa C/efectos de los fármacos , Proteína Quinasa C/metabolismo , Ratas , Ratas Sprague-Dawley , Especies Reactivas de Oxígeno/metabolismo , Canales Aniónicos Dependientes del Voltaje/efectos de los fármacosRESUMEN
Malaria symptoms occur during Plasmodium falciparum development into red blood cells. During this process, the parasites make substantial modifications to the host cell in order to facilitate nutrient uptake and aid in parasite metabolism. One significant alteration that is required for parasite development is the establishment of an anion channel, as part of the establishment of New Permeation Pathways (NPPs) in the red blood cell plasma membrane, and we have shown previously that one channel can be activated in uninfected cells by exogenous protein kinase A. Here, we present evidence that in P. falciparum-infected red blood cells, a cAMP pathway modulates anion conductance of the erythrocyte membrane. In patch-clamp experiments on infected erythrocytes, addition of recombinant PfPKA-R to the pipette in vitro, or overexpression of PfPKA-R in transgenic parasites lead to down-regulation of anion conductance. Moreover, this overexpressing PfPKA-R strain has a growth defect that can be restored by increasing the levels of intracellular cAMP. Our data demonstrate that the anion channel is indeed regulated by a cAMP-dependent pathway in P. falciparum-infected red blood cells. The discovery of a parasite regulatory pathway responsible for modulating anion channel activity in the membranes of P. falciparum-infected red blood cells represents an important insight into how parasites modify host cell permeation pathways. These findings may also provide an avenue for the development of new intervention strategies targeting this important anion channel and its regulation.
Asunto(s)
Proteína 1 de Intercambio de Anión de Eritrocito/fisiología , Proteínas Quinasas Dependientes de AMP Cíclico/metabolismo , Eritrocitos/parasitología , Plasmodium falciparum/fisiología , Proteínas Protozoarias/metabolismo , Canales Aniónicos Dependientes del Voltaje/fisiología , Animales , Proteína 1 de Intercambio de Anión de Eritrocito/efectos de los fármacos , Aniones , Permeabilidad de la Membrana Celular/efectos de los fármacos , Permeabilidad de la Membrana Celular/fisiología , Células Cultivadas , Proteínas Quinasas Dependientes de AMP Cíclico/genética , Electrofisiología , Eritrocitos/efectos de los fármacos , Genes Protozoarios , Interacciones Huésped-Parásitos , Activación del Canal Iónico , Canales Iónicos , Potenciales de la Membrana/efectos de los fármacos , Potenciales de la Membrana/fisiología , Técnicas de Placa-Clamp , Plasmodium falciparum/patogenicidad , Proteínas Protozoarias/genética , Proteínas Recombinantes/farmacología , Canales Aniónicos Dependientes del Voltaje/efectos de los fármacosRESUMEN
This study explores the nature of K fluxes in human lens epithelial cells (LECs) in hyposmotic solutions. Total ion fluxes, Na-K pump, Cl-dependent Na-K-2Cl (NKCC), K-Cl (KCC) cotransport, and K channels were determined by 85Rb uptake and cell K (Kc) by atomic absorption spectrophotometry, and cell water gravimetrically after exposure to ouabain +/- bumetanide (Na-K pump and NKCC inhibitors), and ion channel inhibitors in varying osmolalities with Na, K, or methyl-d-glucamine and Cl, sulfamate, or nitrate. Reverse transcriptase polymerase chain reaction (RT-PCR), Western blot analyses, and immunochemistry were also performed. In isosmotic (300 mosM) media approximately 90% of the total Rb influx occurred through the Na-K pump and NKCC and approximately 10% through KCC and a residual leak. Hyposmotic media (150 mosM) decreased K(c) by a 16-fold higher K permeability and cell water, but failed to inactivate NKCC and activate KCC. Sucrose replacement or extracellular K to >57 mM, but not Rb or Cs, in hyposmotic media prevented Kc and water loss. Rb influx equaled Kc loss, both blocked by clotrimazole (IC50 approximately 25 microM) and partially by 1-[(2-chlorophenyl) diphenylmethyl]-1H-pyrazole (TRAM-34) inhibitors of the IK channel KCa3.1 but not by other K channel or connexin hemichannel blockers. Of several anion channel blockers (dihydro-indenyl)oxy]alkanoic acid (DIOA), 4-2(butyl-6,7-dichloro-2-cyclopentylindan-1-on-5-yl)oxybutyric acid (DCPIB), and phloretin totally or partially inhibited Kc loss and Rb influx, respectively. RT-PCR and immunochemistry confirmed the presence of KCa3.1 channels, aside of the KCC1, KCC2, KCC3 and KCC4 isoforms. Apparently, IK channels, possibly in parallel with volume-sensitive outwardly rectifying Cl channels, effect regulatory volume decrease in LECs.
Asunto(s)
Tamaño de la Célula , Células Epiteliales/metabolismo , Canales de Potasio de Conductancia Intermedia Activados por el Calcio/metabolismo , Activación del Canal Iónico , Cristalino/metabolismo , Potasio/metabolismo , Acetatos/farmacología , Western Blotting , Bumetanida/farmacología , Línea Celular , Permeabilidad de la Membrana Celular , Tamaño de la Célula/efectos de los fármacos , Canales de Cloruro/efectos de los fármacos , Canales de Cloruro/metabolismo , Clotrimazol/farmacología , Ciclopentanos/farmacología , Relación Dosis-Respuesta a Droga , Células Epiteliales/efectos de los fármacos , Humanos , Inmunohistoquímica , Indanos/farmacología , Indenos/farmacología , Canales de Potasio de Conductancia Intermedia Activados por el Calcio/antagonistas & inhibidores , Canales de Potasio de Conductancia Intermedia Activados por el Calcio/genética , Cinética , Cristalino/citología , Cristalino/efectos de los fármacos , Ácido Niflúmico/farmacología , Nitrobenzoatos/farmacología , Ósmosis , Ouabaína/farmacología , Floretina/farmacología , Bloqueadores de los Canales de Potasio/farmacología , Pirazoles/farmacología , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Rubidio , Inhibidores del Simportador de Cloruro Sódico y Cloruro Potásico , Simportadores de Cloruro de Sodio-Potasio/metabolismo , ATPasa Intercambiadora de Sodio-Potasio/antagonistas & inhibidores , ATPasa Intercambiadora de Sodio-Potasio/metabolismo , Espectrofotometría Atómica , Simportadores/metabolismo , Canales Aniónicos Dependientes del Voltaje/efectos de los fármacos , Canales Aniónicos Dependientes del Voltaje/metabolismo , Cotransportadores de K ClRESUMEN
To clarify the role of the mitochondrial permeability transition pore (MPT) in the mechanism of the glutamate-induced delayed calcium deregulation (DCD) and mitochondrial depolarization (MD), we studied changes in cytosolic (pH(c)) and mitochondrial pH (pH(m)) induced by glutamate in cultured cortical neurons expressing pH-sensitive fluorescent proteins. We found that DCD and MD were associated with a prominent pH(m) decrease which presumably resulted from MPT opening. This pH(m) decrease occurred with some delay after the onset of DCD and MD. This argued against the hypothesis that MPT opening plays a dominant role in triggering of DCD. This conclusion was also supported by experiments in which Ca(2+) was replaced with antagonist of MPT opening Sr(2+). We found that in Sr(2+)-containing medium glutamate-induced delayed strontium deregulation (DSD), similar to DCD, which was accompanied by a profound MD. Analysis of the changes in pH(c) and pH(m) associated with DSD led us to conclude that MD in Sr(2+)-containing medium occurred without involvement of the pore. In contrast, in Ca(2+)-containing medium such "non-pore mechanism" was responsible only for MD initiation while in the final stages of MD development the MPT played a major role.
Asunto(s)
Señalización del Calcio/fisiología , Corteza Cerebral/metabolismo , Ácido Glutámico/metabolismo , Mitocondrias/metabolismo , Neuronas/metabolismo , Canales Aniónicos Dependientes del Voltaje/metabolismo , Animales , Animales Recién Nacidos , Calcio/metabolismo , Señalización del Calcio/efectos de los fármacos , Células Cultivadas , Corteza Cerebral/efectos de los fármacos , Corteza Cerebral/ultraestructura , Colorantes Fluorescentes , Ácido Glutámico/farmacología , Concentración de Iones de Hidrógeno/efectos de los fármacos , Potencial de la Membrana Mitocondrial/efectos de los fármacos , Potencial de la Membrana Mitocondrial/fisiología , Mitocondrias/efectos de los fármacos , Mitocondrias/ultraestructura , Membranas Mitocondriales/efectos de los fármacos , Membranas Mitocondriales/metabolismo , Membranas Mitocondriales/ultraestructura , Neuronas/efectos de los fármacos , Neuronas/ultraestructura , Ratas , Ratas Wistar , Estroncio/farmacología , Factores de Tiempo , Canales Aniónicos Dependientes del Voltaje/efectos de los fármacosRESUMEN
A 24-h pretreatment with BNDF enhanced excitotoxic neuronal death in cultured mouse cortical cells challenged with NMDA in the presence of extracellular Mg(2+). The GABA(A) receptor antagonist, bicuculline, enhanced NMDA toxicity in control cultures but, unexpectedly, became neuroprotective in cultures pretreated with BDNF. In contrast, drugs that activate GABA(A) receptors (e.g. muscimol, benzodiazepines, or phenobarbital) or drugs that indirectly enhance GABAergic transmission were protective in control cultures but amplified NMDA toxicity after pretreatment with BDNF. The atypical behaviour of GABAergic drugs in cultures pretreated with BDNF depended on changes in the anion reversal potential because (i) increases in extracellular Cl(-) concentrations abolished the neurotoxic action of muscimol; (ii) muscimol stimulated (36)Cl(-) efflux after pretreatment with BDNF; and (iii) exposure to BDNF reduced the expression of the neuronal K(+)/Cl(-) co-transporter, KCC2. Our data raise the concern that GABAergic drugs may become neurotoxic under conditions associated with increases in brain BDNF levels.
Asunto(s)
Factor Neurotrófico Derivado del Encéfalo/farmacología , Corteza Cerebral/efectos de los fármacos , Corteza Cerebral/metabolismo , Agonistas del GABA/toxicidad , Neuronas/efectos de los fármacos , Neuronas/metabolismo , Animales , Factor Neurotrófico Derivado del Encéfalo/metabolismo , Muerte Celular/efectos de los fármacos , Muerte Celular/fisiología , Células Cultivadas , Cloruros/metabolismo , Cloruros/farmacología , Técnicas de Cocultivo , Interacciones Farmacológicas/fisiología , Agonistas de Aminoácidos Excitadores/toxicidad , Antagonistas del GABA/farmacología , Agonistas de Receptores de GABA-A , Potenciales de la Membrana/efectos de los fármacos , Potenciales de la Membrana/fisiología , Ratones , Fármacos Neuroprotectores/farmacología , Neurotoxinas/toxicidad , Receptores de GABA-A/metabolismo , Canales Aniónicos Dependientes del Voltaje/efectos de los fármacos , Canales Aniónicos Dependientes del Voltaje/metabolismoRESUMEN
Transport mechanisms involved in pH homeostasis are relevant for the survival of Leishmania parasites. The presence of chloride conductive pathways in Leishmania has been anticipated since anion channel inhibitors limit the proton extrusion mediated by the H+ATPase, which is the major regulator of intracellular pH in amastigotes. In this study, we used Xenopus laevis oocytes as a heterologous expression system in which to study the expression of ion channels upon microinjection of polyA mRNA from Leishmania amazonensis. After injection of polyA mRNA into the oocytes, we measured three different types of currents. We discuss the possible origin of each, and propose that Type 3 currents could be the result of the heterologous expression of proteins from Leishmania since they show different pharmacological and biophysical properties as compared to endogenous oocyte currents.